✦ LIBER ✦

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

✍ Scribed by Di Giannatale, Angela; Dias-Gastellier, Nathalie; Devos, Annick; Mc Hugh, Kieran; Boubaker, Ariane; Courbon, Frederic; Verschuur, Arnaud; Ducassoul, Stéphane; Malekzadeh, Katty; Casanova, Michela; Amoroso, Loredana; Chastagner, Pascal; Zwaan, Christian M.; Munzer, Caroline; Aerts, Isabelle; Landman-Parker, Judith; Riccardi, Riccardo; Le Deley, Marie-Cecile; Geoerger, Birgit; Rubie, Hervé

Book ID: 121185110
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 750 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2013.08.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine combined w

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

✍ Birgit Geoerger; Julia Chisholm; Marie-Cecile Le Deley; Jean-Claude Gentet; Chri 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Phase II study of irinotecan in combinat

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

✍ Grill, J.; Geoerger, B.; Gesner, L.; Perek, D.; Leblond, P.; Canete, A.; Aerts, 📂 Article 📅 2013 🏛 Duke University Press 🌐 English ⚖ 113 KB

A phase II study of irinotecan in childr

A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)

✍ Gilles Vassal; Francesco Giammarile; Mariel Brooks; Birgit Geoerger; Dominique C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Dasatinib in Children and Adolescents Wi

Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium

✍ Zwaan, C. M.; Rizzari, C.; Mechinaud, F.; Lancaster, D. L.; Lehrnbecher, T.; van 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB

A phase II study of amrubicin and topote

A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401

✍ Nogami, Naoyuki; Hotta, Katsuyuki; Kuyama, Shoichi; Kiura, Katsuyuki; Takigawa, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB